Pediatrix Medical (MD) Depreciation & Amortization (CF) (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Depreciation & Amortization (CF) data on file, last reported at $6.1 million in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $6.1 million, up 14.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.6 million (down 17.01% YoY), and the FY2025 annual result was $21.8 million, down 32.27% from the prior year.
• Depreciation & Amortization (CF) improved to $6.1 million in Q1 2026 per MD's latest filing, from $5.6 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $10.3 million in Q1 2024 and troughed at $5.3 million in Q2 2025.
• A 5-year average of $7.8 million and a median of $8.8 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) climbed 16.25% in 2022, then plunged 48.27% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $9.1 million in 2022, then declined by 0.81% to $9.1 million in 2023, then retreated by 24.16% to $6.9 million in 2024, then dropped by 18.07% to $5.6 million in 2025, then gained by 8.67% to $6.1 million in 2026.
• Business Quant data shows MD's Depreciation & Amortization (CF) at $6.1 million in Q1 2026, $5.6 million in Q4 2025, and $5.6 million in Q3 2025.